BioCentury
ARTICLE | Clinical News

IX-01: Phase IIa data

February 1, 2016 8:00 AM UTC

The double-blind, U.S. and Australian Phase IIa PEPIX trial in 88 patients with severe lifelong premature ejaculation showed that oral IX-01 given 1-6 hours prior to sexual activity significantly impr...